Key findings from the 2026 report include: Identity breaches surge, driving escalating costs Help desk hijacks…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
Cats Claim Record Share of Veterinary Visits as Feline Market Momentum Builds
New CATalyst Council Report Shows Three-Year Growth Streak, Highest Q3 Feline Market Share on Record ANNAPOLIS,…
Marquee Brands Broadens Global Portfolio with Strategic Acquisition of Stance
Marquee’s 19th Brand Signals a Bold Expansion into Lifestyle and Performance NEW YORK–(BUSINESS WIRE)–#MarqueeBrands–Marquee Brands, the…
LICT Corporation Announces Continuation of Shareholder Designated Charitable Contribution Program
RYE, N.Y.–(BUSINESS WIRE)–The Board of Directors of LICT Corporation (OTC Pink: LICT) is privileged to announce…
Motorola Solutions Acquires Blue Eye, Leading Provider of AI-powered Enterprise Remote Video Monitoring Services
CHICAGO–(BUSINESS WIRE)–Motorola Solutions (NYSE: MSI) today announced it has acquired Blue Eye, a leading provider of…
Navy Federal Credit Union Marks Membership Milestone with Renewed Commitment to Supporting Military Community
As it welcomes its 15 millionth member, Navy Federal commits $10 million this year to organizations…
Bureau Veritas appoints Santiago Arias Duval as Executive Vice-President for the Americas region
PARIS–(BUSINESS WIRE)–Bureau Veritas, a global leader in Testing, Inspection and Certification (TIC), is pleased to announce…
MassMutual and Barings Announce Investment by MS&AD Insurance Group Holdings for 18% Stake in Barings
Strategic partnership with MS&AD to accelerate Barings’ growth with additional capital and assets SPRINGFIELD, Mass. &…
Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)
Pending the European Commission decision, Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide will represent an…
Innate Pharma to Present at Jefferies Global Healthcare Conference
MARSEILLE, France–(BUSINESS WIRE)–#Congress–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”)…